These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18200001

  • 21. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 22. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T, Ozono R, Yano Y, Higashi Y, Teragawa H, Miho N, Ishida T, Ishida M, Yoshizumi M, Kambe M.
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [Abstract] [Full Text] [Related]

  • 23. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K.
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [Abstract] [Full Text] [Related]

  • 24. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C, Ono K, Miyamoto S, Ikai A, Mitani S, Sugimoto N, Tanaka S, Fujita M.
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [Abstract] [Full Text] [Related]

  • 25. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, Nakagawa Y, Nakanishi M, Harada M, Fujiwara M, Murakami M, Ueshima K, Nakao K.
    Circulation; 2009 Sep 01; 120(9):743-52. PubMed ID: 19687356
    [Abstract] [Full Text] [Related]

  • 26. Renal protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats.
    Shudo C, Masuda Y, Sugita H, Furukawa S, Hayashi K, Hirata H, Tanaka S, Tomita K.
    Gen Pharmacol; 1994 Dec 01; 25(8):1567-75. PubMed ID: 7721030
    [Abstract] [Full Text] [Related]

  • 27. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec 01; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 28. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K.
    Nihon Rinsho; 2004 Mar 01; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract] [Full Text] [Related]

  • 29. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Ozawa Y, Saruta T.
    Clin Sci (Lond); 2001 Oct 01; 101(4):421-7. PubMed ID: 11566080
    [Abstract] [Full Text] [Related]

  • 30. Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.
    Okura T.
    Hypertens Res; 2010 Nov 01; 33(11):1112-3. PubMed ID: 20811385
    [No Abstract] [Full Text] [Related]

  • 31. Tight blood pressure control decreases apoptosis during renal damage.
    Soto K, Gómez-Garre D, Largo R, Gallego-Delgado J, Tejera N, Catalán MP, Ortiz A, Plaza JJ, Alonso C, Egido J.
    Kidney Int; 2004 Mar 01; 65(3):811-22. PubMed ID: 14871401
    [Abstract] [Full Text] [Related]

  • 32. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2009 Aug 01; 32(8):670-4. PubMed ID: 19498438
    [Abstract] [Full Text] [Related]

  • 33. Beneficial effect of the long-term treatment with the combination of an ACE inhibitor and a calcium channel blocker on renal injury in rats with 5/6 nephrectomy.
    Flores O, Arévalo M, Gallego B, Hidalgo F, Vidal S, López-Novoa JM.
    Exp Nephrol; 1998 Aug 01; 6(1):39-49. PubMed ID: 9523172
    [Abstract] [Full Text] [Related]

  • 34. Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
    Hayashi K, Koyama M, Kido H, Egi Y, Kubo Y, Shinyama H, Iwamoto M, Nakamura N, Kagitani Y.
    Clin Exp Pharmacol Physiol; 1997 Nov 01; 24(11):831-40. PubMed ID: 9363365
    [Abstract] [Full Text] [Related]

  • 35. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
    Nakano N, Ishimitsu T, Takahashi T, Inada H, Okamura A, Ohba S, Matsuoka H.
    Int Heart J; 2010 May 01; 51(3):188-92. PubMed ID: 20558909
    [Abstract] [Full Text] [Related]

  • 36. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
    Chen J, Gu Y, Lin F, Yang H, Zhu W, Ma J, Lin S.
    Chin Med J (Engl); 2002 Jul 01; 115(7):972-8. PubMed ID: 12150723
    [Abstract] [Full Text] [Related]

  • 37. Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.
    Rajput R, Chavda V, Patel SS, Barreto GE, Ashraf GM.
    J Mol Neurosci; 2021 Sep 01; 71(9):1884-1896. PubMed ID: 34056691
    [Abstract] [Full Text] [Related]

  • 38. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):424-34. PubMed ID: 18331727
    [Abstract] [Full Text] [Related]

  • 39. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
    Koh KK, Quon MJ, Lee SJ, Han SH, Ahn JY, Kim JA, Chung WJ, Lee Y, Shin EK.
    Diabetes Care; 2007 Jun 28; 30(6):1605-7. PubMed ID: 17351278
    [No Abstract] [Full Text] [Related]

  • 40. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H, Shigenobu K.
    Cardiovasc Drug Rev; 2002 Jun 28; 20(1):81-92. PubMed ID: 12070536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.